EV/EBITDA
96.69
-0.29-0.30%
84 min ago
Summary
- As of February 7, 2025, PHAR EV/EBITDA is 96.69, with a fall of -0.29 (-0.30%) during the most recent trading day.
- Over the past year, PHAR EV/EBITDA has dropped by -38.25 (-28.35%).
- PHAR EV/EBITDA is now -37.06% below its all-time high of 153.62.
Performance
PHAR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PHAR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.3% | -0.3% | -0.3% |
| 1 m1 month | -9.0% | -9.0% | -9.9% |
| 3 m3 months | +5.7% | +5.7% | +6.4% |
| 6 m6 months | -29.6% | +9.1% | +11.9% |
| ytdytd | -11.1% | -11.1% | -12.2% |
| 1 y1 year | -28.4% | -27.7% | -26.9% |
| 5 y5 years | - | - | - |
PHAR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -11.8% | 89.60 | +7.9% | |
| 3 m | 3-month | 114.02 | -15.2% | 79.46 | +21.7% |
| 6 m | 6-month | 146.45 | -34.0% | 79.46 | +21.7% |
| 1 y | 1-year | 153.62 | -37.1% | 65.45 | +47.7% |
| 3 y | 3-year | 153.62 | -37.1% | -439.22 | +122.0% |
| 5 y | 5-year | 153.62 | -37.1% | -439.22 | +122.0% |
| alltime | all time | 153.62 | -37.1% | -439.22 | +122.0% |
Pharming Group NV EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 96.69(-11.1%) |
| 2024 | 108.75(-15.3%) |
| 2023 | 128.46(+530.3%) |
| Date | Value |
|---|---|
| 2022 | 20.38(+80.8%) |
| 2021 | 11.27(-29.1%) |
| 2020 | 15.89 |
FAQ
- What is Pharming Group NV EV/EBITDA?
- What is the all time high EV/EBITDA for Pharming Group NV?
- What is PHAR EV/EBITDA year-to-date change?
- What is Pharming Group NV EV/EBITDA year-on-year change?
What is Pharming Group NV EV/EBITDA?
The current EV/EBITDA of PHAR is 96.69
What is the all time high EV/EBITDA for Pharming Group NV?
Pharming Group NV all-time high EV/EBITDA is 153.62
What is PHAR EV/EBITDA year-to-date change?
Pharming Group NV EV/EBITDA has changed by -12.06 (-11.09%) since the beginning of the year
What is Pharming Group NV EV/EBITDA year-on-year change?
Over the past year, PHAR EV/EBITDA has changed by -38.25 (-28.35%)